CD3D
T-cell surface glycoprotein CD3 delta chain
Also known as: CD3-DELTA, CD3D_HUMAN, CD3DELTA, T3D
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04234
- Gene
- CD3D
- Ensembl
- ENSG00000167286
- Chromosome
- 11
- Canonical length
- 171 aa
- Protein class
- CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is part of the T-cell receptor/CD3 complex (TCR/CD3 complex) and is involved in T-cell development and signal transduction. The encoded membrane protein represents the delta subunit of the CD3 complex, and along with four other CD3 subunits, binds either TCR alpha/beta or TCR gamma/delta to form the TCR/CD3 complex on the surface of T-cells. Defects in this gene are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (SCIDBNK). Two transcript variants encoding different isoforms have been found for this gene. Other variants may also exist, but the full-length natures of their transcripts has yet to be defined. [provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
171 residues, UniProt reviewed canonical sequence.
>P04234|CD3D
1 MEHSTFLSGL VLATLLSQVS PFKIPIEELE DRVFVNCNTS ITWVEGTVGT LLSDITRLDL
61 GKRILDPRGI YRCNGTDIYK DKESTVQVHY RMCQSCVELD PATVAGIIVT DVIATLLLAL
121 GVFCFAGHET GRLSGAADTQ ALLRNDQVYQ PLRDRDDAQY SHLGGNWARN KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD3D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 809 nTPM
Expression across tissuesHPA
Tissue
- thymus: 809 nTPM
- lymph node: 185 nTPM
- tonsil: 140 nTPM
- appendix: 64 nTPM
- spleen: 51 nTPM
- small intestine: 34 nTPM
Single-cell type
- t-cells: 567 nCPM
- nk-cells: 57 nCPM
- thymocytes: 51 nCPM
- platelets: 14 nCPM
- gastric chief cells: 11 nCPM
- plasma cells: 9.4 nCPM
Immune cell
- T-reg: 1,630 nTPM
- gdT-cell: 1,435 nTPM
- memory CD8 T-cell: 1,339 nTPM
- naive CD8 T-cell: 1,320 nTPM
- memory CD4 T-cell: 1,185 nTPM
- total PBMC: 1,119 nTPM
Brain region
- medulla oblongata: 1 nTPM
- white matter: 1 nTPM
- choroid plexus: 0.7 nTPM
- hypothalamus: 0.6 nTPM
- spinal cord: 0.6 nTPM
- pons: 0.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CD3D.
Disease | AllUniProt
Conditions CD3D is implicated in, by any mechanism.
- Immunodeficiency 19, severe combined (IMD19) MIM:615617
Disease | GeneticClinVar
17 pathogenic / likely-pathogenic of 229 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency 19
- CD3D-related disorder
- Severe combined immunodeficiency disease
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.46
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.01
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- alpha-beta T cell activation
- cell surface receptor signaling pathway
- positive thymic T cell selection
- T cell receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CD3D in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- CD8
- CD8B
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD3D as an antibody target. Whether an autoantibody or antibody against CD3D could matter depends on whether native CD3D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD3D is annotated at the cell surface, where native CD3D is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CD3D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...